SERUM APOB48 LEVELS ARE ELEVATED IN METABOLIC SYNDROME AND DIABETES MELLITUS

被引：0
|
作者：
Tanimura, K. [1 ]
Nagao, M. [1 ]
Mariko, S. [1 ]
Harada, T. [1 ]
Nakajima, Y. [1 ]
Okajima, F. [1 ]
Asai, A. [1 ]
Kotake, H. [2 ]
Shinichi, O. [1 ]
机构：
[1] Nippon Med Sch, Dept Endocrinol & Metab, Tokyo 113, Japan
[2] Sendai Red Cross Hosp, Sendai, Miyagi, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EZETIMIBE EFFECT ON SERUM apoB48 LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA AND TYPE 2 DIABETES
    Sudo, M.
    Takemitsu, S.
    Sato, Y.
    Nagao, M.
    Harada, T.
    Nakajima, Y.
    Tanimura, K.
    Okajima, F.
    Oikawa, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 84 - 84
  • [2] Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
    Verges, Bruno
    Duvillard, Laurence
    de Barros, Jean Paul Pais
    Bouillet, Benjamin
    Baillot-Rudoni, Sabine
    Rouland, Alexia
    Sberna, Anne-Laure
    Petit, Jean-Michel
    Degrace, Pascal
    Demizieux, Laurent
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (09) : 2198 - 2206
  • [3] Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome
    Mangat, R.
    Su, J.
    Scott, P. G.
    Russell, J. C.
    Vine, D. F.
    Proctor, S. D.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 477 - 481
  • [4] Apob48 as a Marker of Atherosclerosis in Patients with Familial Lipid Disorders, Type 2 Diabetes Mellitus and Coronary Artery Disease
    Alipour, A.
    Valdivielso, P.
    Elte, J. W. F.
    Janssen, J. W.
    Rioja, J.
    Njo, T. L.
    Gonzaalez-Santos, P.
    Rietveld, A. P.
    Castro Cabezas, M.
    CIRCULATION, 2010, 122 (21)
  • [5] Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
    Charles Daniel Meyers
    Karine Tremblay
    Ahmed Amer
    Jin Chen
    Liewen Jiang
    Daniel Gaudet
    Lipids in Health and Disease, 14
  • [6] Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
    Meyers, Charles Daniel
    Tremblay, Karine
    Amer, Ahmed
    Chen, Jin
    Jiang, Liewen
    Gaudet, Daniel
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [7] ApoB48 as a Marker of Atherosclerosis in Patients with Familial Lipid Disorders, Type 2 Diabetes Mellitus and Coronary Artery Disease
    Alipour, A.
    Valdivielso, P.
    Elte, J. W. F.
    Janssen, J. W.
    Rioja, Jose
    Njo, T. L.
    Gonzalez-Santos, P.
    Rietveld, A. P.
    Cabezas, M. Castro
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (01) : 68 - 69
  • [8] Postprandial ApoB48 Levels Determined Using ELISA in Diabetic and Normal Subjects.
    Leonard, A.
    Tun, T. Kyaw
    Gaffney, P.
    Sharma, J.
    Gibney, J.
    Boran, G.
    ENDOCRINE REVIEWS, 2010, 31 (03) : S33 - S33
  • [9] Pleiotropic Effects of APOB Variants on Lipid Profiles, Metabolic Syndrome, and the Risk of Diabetes Mellitus
    Jang, Shih-Jung
    Tuan, Wei-Lun
    Hsu, Lung-An
    Er, Leay-Kiaw
    Teng, Ming-Sheng
    Wu, Semon
    Ko, Yu-Lin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [10] Elevated serum ferritin levels in subjects with type II diabetes mellitus
    Nakatani, K
    Sumida, Y
    Yuda, H
    Katsuki, A
    Ito, K
    Fujii, M
    Tuchihashi, K
    Murata, K
    Goto, H
    Yano, Y
    Misaki, M
    Okazaki, T
    Shima, T
    DIABETOLOGIA, 1996, 39 : 795 - 795
12345